Free Trial

Senti Biosciences (SNTI) Short Interest Ratio & Short Volume

Senti Biosciences logo
$2.33 +0.08 (+3.56%)
(As of 05:20 PM ET)

Senti Biosciences Short Interest Data

Senti Biosciences (SNTI) has a short interest of 65,100 shares, representing 2.27% of the float (the number of shares available for trading by the public). This marks a 9.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 227,044 shares to cover all short positions.

Current Short Interest
65,100 shares
Previous Short Interest
59,200 shares
Change Vs. Previous Month
+9.97%
Dollar Volume Sold Short
$141,267.00
Short Interest Ratio
2.5 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
4,580,000 shares
Float Size
2,870,000 shares
Short Percent of Float
2.27%
Today's Trading Volume
3,011 shares
Average Trading Volume
227,044 shares
Today's Volume Vs. Average
1%
Short Selling Senti Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SNTI Short Interest Over Time

SNTI Days to Cover Over Time

SNTI Percentage of Float Shorted Over Time

Senti Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202465,100 shares $141,267.00 +10.0%2.3%2.5 $2.17
10/15/202459,200 shares $120,477.92 -14.7%2.1%1.4 $2.04
9/30/202469,400 shares $156,844.00 -0.7%2.4%1.4 $2.26
9/15/202469,900 shares $214,593.00 -9.5%2.4%0.1 $3.07
8/31/202477,200 shares $204,580.00 -30.9%2.7%0.1 $2.65
8/15/2024111,700 shares $255,793.00 +86.2%4.0%0.2 $2.29
7/31/202460,000 shares $138,600.00 +38.9%2.2%0.1 $2.31
7/15/202443,200 shares $136,036.80 -70.6%1.6%0.1 $3.15
6/30/20241,470,000 shares $405,720.00 +443.0%5.3%0.2 $0.28
6/15/2024270,700 shares $66,700.48 +8.5%1.0%0.3 $0.25
5/31/2024249,500 shares $74,850.00 -11.3%0.9%2 $0.30
5/15/2024281,400 shares $106,366.39 -2.1%1.0%2.6 $0.38
4/30/2024287,300 shares $103,428.00 +73.9%1.1%2.5 $0.36
4/15/2024165,200 shares $49,758.24 -22.7%0.6%2 $0.30
3/31/2024213,800 shares $80,623.98 -4.2%0.8%2.1 $0.38
3/15/2024223,200 shares $83,253.60 -17.3%0.8%0.3 $0.37
2/29/2024269,900 shares $116,057.00 -21.9%1.0%0.4 $0.43
2/15/2024345,400 shares $146,795.00 +15.1%1.3%0.5 $0.43
1/31/2024300,000 shares $135,030.00 -30.4%1.2%0.1 $0.45
1/15/2024430,700 shares $232,147.30 -44.1%1.6%0.2 $0.54
12/31/2023769,900 shares $508,134.00 +60.8%2.9%0.3 $0.66
12/15/2023478,900 shares $182,987.69 -42.6%1.8%0.2 $0.38
11/30/2023834,000 shares $358,703.40 -44.4%3.2%0.3 $0.43
11/15/20231,500,000 shares $557,700.00 +260.1%5.7%0.6 $0.37
10/31/2023416,500 shares $116,536.70 -8.2%1.6%0.2 $0.28
10/15/2023453,800 shares $137,002.22 +100.6%1.7%1.6 $0.30
9/30/2023226,200 shares $93,420.60 +7.2%0.9%0.9 $0.41
9/15/2023211,000 shares $122,823.10 -32.7%0.8%2.9 $0.58
8/31/2023313,400 shares $203,710.00 -6.8%1.5%4.6 $0.65
8/15/2023336,300 shares $242,472.30 -10.1%1.6%4.8 $0.72
7/31/2023374,200 shares $322,560.40 -12.3%1.9%5.3 $0.86
7/15/2023426,500 shares $298,550.00 +24.9%2.1%4.4 $0.70
6/30/2023341,400 shares $214,057.80 -15.1%1.4%3.5 $0.63
6/15/2023402,300 shares $402,300.00 -12.8%1.6%4.6 $1.00
5/31/2023461,100 shares $407,566.29 -11.0%1.8%5.3 $0.88
5/15/2023517,900 shares $502,363.00 +2.9%2.0%5.8 $0.97
4/30/2023503,500 shares $493,430.00 -0.5%1.9%5.4 $0.98
4/15/2023506,100 shares $541,527.00 +0.2%2.0%4.9 $1.07
3/31/2023505,200 shares $596,136.00 -9.0%2.0%5.3 $1.18
3/15/2023555,200 shares $705,104.00 +12.6%2.2%5.4 $1.27
Elon Musk has put himself in their crosshairs (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.
2/28/2023493,100 shares $739,650.00 -4.4%1.9%2.7 $1.50
2/15/2023515,500 shares $860,885.00 -13.1%2.0%2.8 $1.67
1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83
1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89
12/30/2022615,500 shares $867,855.00 +65.6%1.8%0.9 $1.41
12/15/2022371,800 shares $565,136.00 -12.3%1.1%0.1 $1.52
11/30/2022423,900 shares $974,970.00 -6.8%1.2%0.1 $2.30
11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43
10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32
10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27
9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17
9/15/2022180,100 shares $405,225.00 -23.0%0.5%0.1 $2.25
8/31/2022234,000 shares $458,640.00 -16.1%0.7%0.2 $1.96
8/15/2022278,800 shares $568,752.00 -3.5%0.8%0.2 $2.04
7/31/2022288,900 shares $904,257.00 +110.1%0.9%0.2 $3.13
7/15/2022137,500 shares $247,500.00 No Change0.4%0.4 $1.80

SNTI Short Interest - Frequently Asked Questions

What is Senti Biosciences' current short interest?

Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 65,100 shares of SNTI short. 2.27% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest.

What is a good short interest ratio for Senti Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 2.0. Learn More on Senti Biosciences's short interest ratio.

What is a good short interest percentage for Senti Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.27% of Senti Biosciences' floating shares are currently sold short.

Is Senti Biosciences' short interest increasing or decreasing?

Senti Biosciences saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 65,100 shares, an increase of 10.0% from the previous total of 59,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Senti Biosciences' float size?

Senti Biosciences currently has issued a total of 4,580,000 shares. Some of Senti Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Senti Biosciences currently has a public float of 2,870,000 shares.

How does Senti Biosciences' short interest compare to its competitors?

2.27% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Senti Biosciences: Carisma Therapeutics, Inc. (4.00%), Achilles Therapeutics plc (0.41%), Passage Bio, Inc. (3.21%), Elevation Oncology, Inc. (12.42%), CERo Therapeutics Holdings, Inc. (3.91%), DURECT Co. (3.35%), Lantern Pharma Inc. (2.06%), Daré Bioscience, Inc. (0.35%), CalciMedica, Inc. (1.36%), OKYO Pharma Limited (1.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Senti Biosciences stock?

Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. SNTI shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Senti Biosciences?

A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further.

How often is Senti Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:SNTI) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners